Company: CMND
Filing Date: 2025-09-15
Form Type: POS AM
Source: 0001213900-25-087398
Chunk: 45

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-15
Form: POS AM
Chunk 45
---
 change in the information set forth in the registration 
 statement. Notwithstanding the foregoing, any increase or decrease in volume of securities           
 offered (if the total dollar value of securities offered would not exceed that which was             
 registered) and any deviation from the low or high end of the estimated maximum offering             
 range may be reflected in the form of prospectus filed with the Commission pursuant to Rule          
 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change       
 in the maximum aggregate offering price set forth in the “Calculation of Registration                
 Fee” table in the effective registration statement;                                                  |

| iii. | To include any material information with respect to                                                                               
 the plan of distribution not previously disclosed in the registration statement or any material change to such information in the 
 registration statement.                                                                                                           |

| (2) | That, for the purpose of determining any liability                                                                                    
 under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to           
 the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering 
 thereof.                                                                                                                              |

| (3) | To remove from registration by means of a post-effective amendment                             
 any of the securities being registered which remain unsold at the termination of the offering. |

| (4) | To file a post-effective amendment to the registration                                                                               
 statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout  
 a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, 
 provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required       
 pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least 
 as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on Form 
 F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3)       
 of the Act or Rule 3-19 of this chapter if such financial statements and information are contained in periodic reports filed         
 with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 
 that are incorporated by reference in the Form F